WASHINGTON (MedPage Today) -- A year after implant, a everolimus-eluting bioreabsorbable scaffold (Absorb) was as good as a everolimus-eluting metal stent (Xience), but may have been more effective at reducing angina, researchers reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment